The stabilization of phosphoenolpyruvate carboxykinase mRNA by glucocorticoids appears to result from the interaction of an induced factor with an RNA element located in the 3' noncoding sequence of the mRNA. This element can confer glucocorticoid-dependent stabilization upon a heterologous mRNA, and thus strategies developed to investigate the control of mRNA transcription can now be applied to the analysis of hormone-regulated mRNA stabilization.
medium was added to cell cultures 24 hr before the pulsechase experiment. Half of the cells were treated with 50 nM dexamethasone for 16 hr prior to and during the chase period; the other half were treated for 4 hr prior to and during the chase.
[3H]Uridine (2 mCi, 1 Ci = 37 GBq) was added to 150-cm2 culture flasks containing 10 ml of medium and incubated for 2 hr. At time zero flasks were washed twice with serum-free medium and then incubated with fresh medium containing 20 mM uridine for various times. The labeled RNA was hybridized to nitrocellulose filter disks bearing an immobilized 5800-base-pair (bp) PEPCK genomic DNA probe (18) . Radioactivity specifically bound to the PEPCK filter disk was quantified by liquid scintillation and expressed as a fraction (ppm) of the total [3H]UTP incorporated (18) . The same procedure was used to determine the effect of dexamethasone on actin mRNA stability, except that cells were exposed to the hormone for 16 hr, and the labeled RNA was annealed to a 2100-bp rat actin probe (pBAc2995).
Plasmid Constructions. The CATCK fusion gene plasmid pCATCK, consisting ofpromoter and enhancer elements from simian virus 40 (SV40), the chloramphenicol acetyltransferase (CAT) coding sequences, and 3' noncoding sequences from PEPCK, was constructed by replacing the SV40 splice and polyadenylylation sequences in plasmid SV2CAT with the analogous sequences from the PEPCK gene. The 1300-bp EcoRI-BamHI fragment from pPC112.RI (19) was inserted into the BamHI site of pSV2CAT from which the SV40 splice and polyadenylylation sequences had been deleted by replacing the Mbo I-BamHI fragment from pSV2CAT with a BamHI linker. The plasmid pCKTCAT (see Fig. 2A ) was constructed by inserting the same EcoRI-BamHI 3' noncoding sequence of PEPCK mRNA into the BamHI site of pBLCAT. This vector contains the herpes simplex virus thymidine kinase promoter (positions from -105 to +51 relative to the site oftranscription initiation). The composition and construction of the other plasmids used have been described (15) . For example, pPG32TKCAT contains a PEPCK gene glucocorticoid response element (from the 5' flanking sequence between positions -600 and -108) ligated into the HindIII site ofpTKCAT, pPL9 consists of the sequence from position -600 to position +69 of the PEPCK gene ligated to the CAT reporter gene, and TKCAT consists of the herpes simplex virus thymidine kinase promoter sequence (positions -105 to +50) ligated to the CAT reporter gene. (Fig. 1A) . The (18) . Actin mRNA, unaffected by dexamethasone, was quantitated in each sample and this was used to correct the PEPCK mRNA value for differences in RNA loading on the gel. PEPCK was corrected for the total protein in each sample. The error bars represent the SEM (n = 2-10), at the various time points. Similar conditions were used to analyze the effect of dexamethasone on PEPCK mRNA degradation. The uridine and UTP pools in control and glucocorticoid-treated H4IIE cells were measured (20) to exclude the possibility that the hormone affected the size of these pools and thus the specific activity of the labeled RNA. The addition of dexamethasone had no effect on the steady-state specific activity of the uridine or UTP pools. The ta12 of PEPCK mRNA was quantified by measuring the disappearance of radioactivity in a pulse-chase assay. The radioactivity (expressed as ppm of total RNA) is shown as a function of the time of the chase period; the error bars represent the SEM (n = 3-7). Radioactivity in PEPCK mRNA was measured in cells treated for 4 hr (o) or 16 hr (0) before initiation of the chase with unlabeled uridine (B). The t1/2 values were determined from the slope of a single line fitted by linear regression to the data accumulated using cells treated with dexamethasone for 16 hr and from the initial and final slopes of the data obtained using cells treated with dexamethasone for 4 hr prior to the initiation of the chase.
turnover. The t1/2 during the initial phase was 33 min, which is similar to that estimated using a variety of techniques (16, 21, 22) . One to 2 hr after the start of the chase period (5-7 hr after the addition of dexamethasone), a marked prolongation of the t1/2 was noted (Fig. 1B) . Beyond this time the t'12 approximated Biochemistry: Petersen et made using plasmids pSV2CAT and pCATCK ( Fig. 2A) . Transcription of the reporter gene in these vectors is under the control of the SV40 enhancer/promoter, which was not glucocorticoid responsive ( Fig. 2 B and C) (Fig. 3) . In contrast, PEPCK mRNA was markedly increased within 3 were quantitated. Actin mRNA was used to correct for differences in RNA loading between samples, as described in Fig. 1 Bluescript   FIG. 4 . GRS is not a transcription enhancer. Analysis of the effect of dexamethasone on transcription ofthe PEPCK and CATCK genes, and on gene 33, is presented. CATCK-6 cells were incubated in 0.5 AsM dexamethasone for 30 or 60 min. Nuclei were then isolated and transcription of these genes (and of the corresponding cloning vectors pBR322 and Bluescript as controls) was measured by the in vitro nuclear run-on procedure, except that the hybridization reactions were quantitated by autoradiography.
hr, a response that was qualitatively similar to that seen in the experiment illustrated in Fig. LA . Thus, the induction of CATCK mRNA by glucocorticoids resembled the late-phase induction of PEPCK mRNA. Attempts to demonstrate that the induction of a protein is required for the conversion of the mRNA to the more stable form have, to date, been unsuccessful. Prolonged exposure (6-8 hr) of CATCK-2 and CATCK-6 cells to cycloheximide, at concentrations that block protein synthesis, not only blunted the CATCK mRNA response to dexamethasone but also resulted in a significant decrease of PEPCK mRNA, actin mRNA, and of the incorporation of [3H]uridine into total cell RNA.
Exclusion of Enhancer Function for the GRS. Transcription of the chimeric CATCK gene was compared to that of the endogenous PEPCK gene to exclude the possibility that the 3' noncoding region was responding to dexamethasone as a transcription enhancer or glucocorticoid-response element. Dexamethasone caused a rapid 4-to 5-fold increase ofPEPCK gene transcription in CATCK-6 cells (Fig. 4) . Transcription of gene 33, another gene known to be positively regulated by glucocorticoids in H4IIE cells (23) , was also increased. The low level of transcription of the CAT gene in the CATCK-6 cells was unaffected by dexamethasone (Fig. 4) .
Further evidence against the 3' noncoding sequence acting as a glucocorticoid-response element was obtained using a construction (pCKTCAT; Fig. 2A ) in which this element was ligated on the 5' side of the transcription initiation site of the CAT reporter. Dexamethasone had no effect on CAT activity in cells transfected with the pCKTCAT construction but did induce CAT activity in cells transfected with plasmids containing a PEPCK gene that was linked by the glucocorticoidresponse element to the CAT gene by either the thymidine kinase or PEPCK promoter ( Table 1 ). The GRS worked only when located downstream from the CAT gene, which is consistent with its proposed role. 
DISCUSSION
Acute metabolic adaptation is achieved by modification of the activity of key enzymes, whereas chronic adaptation is accomplished through altered rates of enzyme synthesis. The latter, facilitated by changes in the amount of the corresponding mRNA, is the only mechanism involved in the regulation of PEPCK, the rate-controlling enzyme in gluconeogenesis. By regulating independent events in the metabolism of PEPCK mRNA, the stimulatory effect of glucocorticoids produces a gradual increase in the amount of PEPCK until another steady state is achieved. This presumably provides a continuous flux of noncarbohydrate precursors into the gluconeogenic pathway. Transcription, mediated by the two glucocorticoid-response elements located in the DNA sequence that flanks the cap site (15) , and degradation, mediated by the GRS located in the 3' noncoding sequence of the mRNA, are both involved in this important physiologic action of glucocorticoid hormones.
Much has been learned about the turnover of mRNA (1, 24) . Most mRNAs in mammalian cells are very stable and have a til2 measured in hours. Some, however, turn over very rapidly (til2 = 10-30 min) and in certain instances this process is subject to regulation. It appears that the ends of mRNA molecules govern their stability. The 5' cap structure in eukaryotic mRNA prevents attack by 5' exonucleases and the poly(A) tail prohibits the action of 3' exonucleases. In mRNA molecules with those structures, it is presumed that a single endonucleolytic cut allows exonucleases to attack and digest the entire molecule. Other structures at either end are thought to promote or prevent this initial endonucleolytic action. There is evidence of a role for structures in or associated with the 5' end of certain eukaryotic mRNAs (25, 32) but most attention has been focused on the 3' noncoding sequence.
Structures at the 3' end enhance or diminish the stability of specific mRNAs. The absence of a poly(A) tail is associated with rapid degradation of mRNA (26) . Histone mRNAs lack a poly(A) tail but have a sequence near their 3' terminus that can form a stem-loop structure; this appears to confer resistance to exonucleolytic attack (27) . Stem-loop structures in the 3' noncoding sequence are also critical for the regulation, by iron, of the mRNA encoding the transferrin receptor (28) . Other sequences in the 3' end of certain eukaryotic mRNAs appear to be involved in the destabilization of these molecules. Of particular interest are A+U-rich regions, many of which contain the sequence AUUUA. This sequence appears in mRNAs that have a very short til2, including mRNAs for granulocyte-macrophage colonystimulating factor (29), c-fos (30) , and c-myc (31) . The importance of this region is underscored by an experiment in which a sequence containing the 3' noncoding region of the granulocyte-macrophage colony-stimulating mRNA, which includes the AUUUA motif, was added to the f3globin gene.
The addition of this region onto the 3' end of the 3-globin mRNA destabilized this transcript (29) .
How can what is known about the turnover of eukaryotic mRNA be used to infer the mechanism of action of the GRS? PEPCK mRNA has a poly(A) tail (19) , which is a potential site of regulation (9) . In addition, the 3' noncoding sequence contains a 102-nucleotide stretch of alternating purines and pyrimidines, occurring in a predominately UpG pattern, and the numerous palindromes and repeat sequences in this region could form stem-loop structures (19) . The sequence motif AUUUA is also present in this region of PEPCK mRNA. Transfection experiments using truncated portions of the 3' noncoding sequence should enable us to determine whether any of these elements are involved in determining the dexamethasone-regulated stability of PEPCK mRNA or whether some other sequence is involved.
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The observation that hormone-regulated control of mRNA stability can be transferred to a heterologous mRNA by a portion of the 3' noncoding region of PEPCK mRNA provides functional evidence for a GRS. Whether this represents a general mechanism, involved in many of the examples where mRNA stability is regulated by hormones, remains to be established. It is becoming more apparent that cells employ a variety of mechanisms to regulate mRNA stability (1, 24) , just as the synthesis of mRNA is controlled in numerous ways. A hormone that affects mRNA transcription and stability, through physically and temporally separate processes, affords the cell flexibility in adapting to a constantly changing environment.
